IL-12_ge.ng Therapv_-U.siag..direct injection of tumors with genetically 
engineered aut ologous fibroblasts 
Principal Invast igators < 
Hideaki Tahara, M.D., Ph.D. 
Michael T. Lotze, M.D. 
Coprincipal invest igators t 
Paul D Robbins, Ph.D. 
Walter J. Storkus, Ph.D. 
Laurence Zitvogel, M.D. 
Associate Investigators! 
5.arfllgal Oncology 
Howard Edington, M.D. 
Jeffrey l^ers, M.D., Ph.D. 
Chet Nastala, M.D. 
Itzhak Pappo, M.D. 
Joshua T. Rubin, M.D. 
Herbert J. Zeh III, M.D. 
Medical Oncology 
John Kirkwood, M.D. 
Theodore Logan, M.D. 
Urology 
Raoul R. Salup. M.D., 
Radiation Therapy 
Maury Rosenstein, Ph.D., M.D. 
Molecular Genetics and Biochemistry 
Gunhild M. Mueller. Ph.D. 
Joseph C. Glorioso, Ph.D. 
Cell Biology and Physiology 
Simon C. Watkins, Ph.D. 
Theresa Whiteside, Ph.D. 
Elaine Elder, Ph.D. 
HUffiAB Gone Therapy Applications Laboratory (HGTAL). 
John A. Barranger, M.D., Ph.D. 
Alfred Bahnson, Ph.D. 
gthlgi 
Rosa Lynn Pinkus, Ph.D. 
Statistics 
John Bryant, Ph.D. 
[6461 
Genetics Institute, Inc. 
Stanley F. Wolf, Ph.D. 
Hof faann-La Roshi iBiLi. 
Maurice K. Gately, Ph.D. 
Ueli Gubler, Ph.D. 
Recombinant DNA Research, Volume 19 
